3 ms·
Pfizer's CEO sold on November 9th, on a day the stock closed at $37.14. It peaked last week (the 8th) at $42.56, and closed today at $37.84, so I'm not sure wha
by Sebguer 6y ago
Pfizer's CEO sold on November 9th, on a day the stock closed at $37.14. It peaked last week (the 8th) at $42.56, and closed today at $37.84, so I'm not sure what you're talking about.
- validuser 6y agoHis trade was another pretty obvious inside trade (timed the announcement of their successful trials with the scheduled sale)
- Sebguer 6y agoIt was a sale that had been scheduled months previously, and it should by now be obvious that the trial really was successful!
- waheoo 6y agoYou think it's hard to schedule a well timed press release in a way that works in well with your predetermined share sales?
- wpietri 6y agoI don't know about this sale in specific, but isn't it a common trick for execs to schedule sales in advance and then cancel if it turns out not to be the right time to sell?
- fractionalhare 6y agoNo, the SEC also considers that illegal insider trading. They actively monitor for this "trick" and aggressively pursue an investigation if there isn't a very good reason for a scheduled trade to be cancelled.
- kennywinker 6y agoSo he didn't know this was the date that the trail results would be announced months previously?
- Sebguer 6y agoThis chain of thought would make sense if the press release were overly optimistic or otherwise misleading... But he didn't even sell at the peak?
- ALittleLight 6y agoOr he could've influenced the announce date to coincide with his sale.